
|Videos|July 24, 2021
Pipeline: Presbyopia, night vision disturbance up next for Vyluma
Advertisement
Presbyopia and night vision disturbance will follow myopia as a clinical focus for Vyluma. Navneet Puri, PhD, the company’s founder, chairman, and CEO, shares what is next.
Newsletter
Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Optometry Times - Clinical News & Expert Optometrist Insights
1
What to know about the most recent treatment and management developments in AMD
2
Higher head elevation during sleep may be associated with higher IOP, study suggests
3
What Yuvezzi brings to the optometrist's clinical toolkit with Dr Derek Cunningham
4
Contact Lens Institute rings in 2026 Visionaries
5




























